Microglia damage precedes major myelin breakdown in X‐linked adrenoleukodystrophy and metachromatic leukodystrophy
暂无分享,去创建一个
W. Brück | C. Hartmann | C. Stadelmann | S. Nessler | G. Stoltenburg‐Didinger | F. van der Meer | S. Hametner | Caroline G Bergner | Claudia Wrzos | S. Pfeifenbring | A. Winkler | D. Fitzner | Emil Valizada | Mevlude Türkmen | C. Bergner
[1] F. Ginhoux,et al. Microglia heterogeneity along a spatio–temporal axis: More questions than answers , 2018, Glia.
[2] F. C. Bennett,et al. A Combination of Ontogeny and CNS Environment Establishes Microglial Identity , 2018, Neuron.
[3] M. Bugiani,et al. Heat shock protein expression in cerebral X‐linked adrenoleukodystrophy reveals astrocyte stress prior to myelin loss , 2018, Neuropathology and applied neurobiology.
[4] N. Popitsch,et al. Impaired plasticity of macrophages in X-linked adrenoleukodystrophy , 2018, Brain : a journal of neurology.
[5] M. Esteller,et al. Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation , 2018, Brain pathology.
[6] Bo Peng,et al. Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion , 2018, Nature Neuroscience.
[7] J. Grutzendler,et al. Lifelong cortical myelin plasticity and age-related degeneration in the live mammalian brain , 2018, Nature Neuroscience.
[8] W. Möbius,et al. Defective cholesterol clearance limits remyelination in the aged central nervous system , 2018, Science.
[9] H. Weiner,et al. Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts , 2017, Brain pathology.
[10] F. Eichler,et al. Microglial dysfunction as a key pathological change in adrenomyeloneuropathy , 2017, Annals of neurology.
[11] David A. Williams,et al. Hematopoietic Stem‐Cell Gene Therapy for Cerebral Adrenoleukodystrophy , 2017, The New England journal of medicine.
[12] Tuan Leng Tay,et al. A new fate mapping system reveals context-dependent random or clonal expansion of microglia , 2017, Nature Neuroscience.
[13] Simon Hametner,et al. Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis , 2017, Brain : a journal of neurology.
[14] F. C. Bennett,et al. Diverse Requirements for Microglial Survival, Specification, and Function Revealed by Defined-Medium Cultures , 2017, Neuron.
[15] A. Linkermann,et al. The in vivo evidence for regulated necrosis , 2017, Immunological reviews.
[16] A. Mildner,et al. P2Y12 receptor is expressed on human microglia under physiological conditions throughout development and is sensitive to neuroinflammatory diseases , 2017, Glia.
[17] Hoon-Chul Kang,et al. 25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome , 2016, Nature Communications.
[18] I. Amit,et al. Microglia development follows a stepwise program to regulate brain homeostasis , 2016, Science.
[19] Steffen Jung,et al. Age-related myelin degradation burdens the clearance function of microglia during aging , 2016, Nature Neuroscience.
[20] Tuan Leng Tay,et al. The force awakens: insights into the origin and formation of microglia , 2016, Current Opinion in Neurobiology.
[21] J. Keane,et al. Lysosomal Disorders Drive Susceptibility to Tuberculosis by Compromising Macrophage Migration , 2016, Cell.
[22] F. C. Bennett,et al. New tools for studying microglia in the mouse and human CNS , 2016, Proceedings of the National Academy of Sciences.
[23] W. Talbot,et al. The Rag-Ragulator Complex Regulates Lysosome Function and Phagocytic Flux in Microglia. , 2016, Cell reports.
[24] J. Berger,et al. Peroxisomes in brain development and function , 2015, Biochimica et biophysica acta.
[25] M. Prinz,et al. Do not judge a cell by its cover—diversity of CNS resident, adjoining and infiltrating myeloid cells in inflammation , 2015, Seminars in Immunopathology.
[26] Frauke Zipp,et al. Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System. , 2015, Immunity.
[27] F. Eichler,et al. The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. , 2015, The application of clinical genetics.
[28] F. Geissmann,et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors , 2014, Nature.
[29] Haoxing Xu,et al. Lysosomal physiology. , 2015, Annual review of physiology.
[30] M. Engelen,et al. Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy , 2014, Neurology.
[31] Klaus-Armin Nave,et al. Myelination of the nervous system: mechanisms and functions. , 2014, Annual review of cell and developmental biology.
[32] I. Bechmann,et al. Microglial pathology , 2014, Acta neuropathologica communications.
[33] Marco Prinz,et al. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease , 2014, Nature Reviews Neuroscience.
[34] Brian L. West,et al. Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain , 2014, Neuron.
[35] S. Gordon,et al. The M1 and M2 paradigm of macrophage activation: time for reassessment , 2014, F1000prime reports.
[36] S. Amor,et al. Oligodendrocyte‐microglia cross‐talk in the central nervous system , 2014, Immunology.
[37] H. Stockinger,et al. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes , 2013, Human molecular genetics.
[38] S. Gygi,et al. Identification of a Unique TGF-β Dependent Molecular and Functional Signature in Microglia , 2013, Nature Neuroscience.
[39] F. Eichler,et al. Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy. , 2012, Brain : a journal of neurology.
[40] K. Moore,et al. Macrophages in the Pathogenesis of Atherosclerosis , 2011, Cell.
[41] P. Aubourg,et al. Current and Future Pharmacological Treatment Strategies in X‐Linked Adrenoleukodystrophy , 2010, Brain pathology.
[42] M. Sofroniew,et al. Astrocytes: biology and pathology , 2009, Acta Neuropathologica.
[43] F. Eichler,et al. Metachromatic Leukodystrophy: A Scoring System for Brain MR Imaging Observations , 2009, American Journal of Neuroradiology.
[44] W. Streit,et al. Life and Death of Microglia , 2009, Journal of Neuroimmune Pharmacology.
[45] A. Moser,et al. Is microglial apoptosis an early pathogenic change in cerebral X‐linked adrenoleukodystrophy? , 2008, Annals of neurology.
[46] M. Eckhardt. The Role and Metabolism of Sulfatide in the Nervous System , 2008, Molecular Neurobiology.
[47] V. Gieselmann. Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options , 2008, Acta paediatrica.
[48] H. Kettenmann,et al. Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.
[49] H. Moser,et al. Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study , 2007, The Lancet Neurology.
[50] S. Renowden,et al. Magnetic Resonance of Myelination and Myelin Disorders , 2006, Journal of Neurology.
[51] R. Lüllmann-Rauch. History and Morphology of the Lysosome , 2005 .
[52] R. Lüllmann-Rauch,et al. Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution , 2004, Acta Neuropathologica.
[53] H. Moser,et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. , 2004, Blood.
[54] J. Peiffer. Über die metachromatischen Leukodystrophien (Typ Scholz) , 2004, Archiv für Psychiatrie und Nervenkrankheiten.
[55] Kazuhide Inoue,et al. Selective expression of Gi/o‐coupled ATP receptor P2Y12 in microglia in rat brain , 2003, Glia.
[56] H. Moser,et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy , 2003, Neurology.
[57] H. Moser,et al. X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression. , 2000, AJNR. American journal of neuroradiology.
[58] Y. Fukuuchi,et al. Microglia-specific localisation of a novel calcium binding protein, Iba1. , 1998, Brain research. Molecular brain research.
[59] K. Jellinger,et al. Alzheimer Disease: DMA Fragmentation Indicates Increased Neuronal Vulnerability, but not Apoptosis , 1998, Journal of neuropathology and experimental neurology.
[60] H. Dusoir,et al. Long-term stabilization after bone marrow transplantation in juvenile metachromatic leukodystrophy. , 1998, Archives of neurology.
[61] Hans Lassmann,et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions , 1995, Annals of neurology.
[62] H. Moser,et al. Adrenoleukodystrophy: a scoring method for brain MR observations. , 1994, AJNR. American journal of neuroradiology.
[63] K. Figura,et al. Molecular genetics of metachromatic leukodystrophy , 1991, Human mutation.
[64] H. Wacker,et al. Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[65] K Suzuki,et al. Adrenoleukodystrophy. A clinical and pathological study of 17 cases. , 1975, Archives of neurology.
[66] J. Peiffer. [On metachromatic leukodystrophy (Scholz type)]. , 1959, Archiv fur Psychiatrie und Nervenkrankheiten, vereinigt mit Zeitschrift fur die gesamte Neurologie und Psychiatrie.